National Influenza Vaccine Summit
preventinfluenza.org
Home | National Influenza Vaccine Summit | For Healthcare Professionals | For the Public
 
 Healthcare Professionals  
 HCP Home
 Influenza Disease
 Later Season Vaccination
 Recommendations
 Special Populations
 Vaccine Pocket Guides
 Vaccine Production
 Vaccination Resources
 Vaccinating HCWs
Order free laminated Influenza Pocket Guides for front-line healthcare providers.

UPenn Fights Influenza:
Baby, Be Wise -- Immunize!

Using song and lyrics to raise awareness of the importance of influenza vaccination for HCWs, the Hospital of the University of Pennsylvania created this 5-minute video featuring scores of employees lip-synching to a doo-wop beat.
Information for Healthcare Professionals
Influenza - prevent a bad disease with a good vaccine!
Vaccine Production, Ordering, and Distribution
Seasonal Influenza Vaccines for the 2012-2013 Season
Manufacturer Trade Name How Supplied Mercury
Content
(mcg
Hg/0.5
mL dose)
Age Group
CSL Biotherapies
(Distributed by Merck Vaccines)
Afluria 0.5 mL (single-dose syringe) 0 9 years & older
5.0 mL (multi-dose vial) 24.5
GlaxoSmithKline (GSK) Fluarix 0.5 mL (single-dose syringe) 0 36 months & older
ID Biomedical Corporation of Quebec
(Distributed by GlaxoSmithKline)
FluLaval 5.0 mL (multi-dose vial) 25 18 years & older
MedImmune FluMist 0.2 mL (single-use sprayer) 0 2 through 49 years
Novartis Vaccines Fluvirin 0.5 mL (single-dose syringe) <1 4 years and older

5.0 mL (multi-dose vial)

25
Agiflu 0.5 mL (single-dose syringe) 0

18 years & older

sanofi pasteur Fluzone 0.25 mL (single-dose syringe) 0 6 through 35 months
5.0 mL (multi-dose vial) 25 6 through 35 months
0.5 mL (single-dose syringe) 0 36 months & older
0.5 mL (single-dose vial)

0

36 months & older
5.0 mL (multi-dose vial) 25 3 years & older
Fluzone High-Dose 0.5 mL (single-dose syringe) 0 65 years & older
Fluzone Intradermal 0.1 mL (single-dose microinjection
system)
0 18 through 64 years

Seasonal Influenza Vaccine Ordering
Most providers order influenza vaccine for the coming vaccination season in the winter and spring of the preceding year. Depending on many factors, orders can be placed direct with the manufacturer, with a distributor, the state's VFC program, or a group purchasing arrangement.

During vaccination seasons when vaccine supply is challenged, the Influenza Vaccine Availability Tracking System (IVATS) also becomes operational. The system was activated in early November of 2012 in response to the devastation caused by Hurricane Sandy when many clinics were without power and consequently lost their supply of vaccine. IVATS enables healthcare providers to view at a glance which distributors have vaccine available to sell.

Order from a manufacturer: To order either Fluarix (GSK) or FluZone (sanofi pasteur), contact the manufacturer.

Order from a distributor: To order FluLaval (GSK), FluMist (MedImmune), or FluVirin (Novartis), contact one of the many distributors that you will find here.

View vaccine currently for sale on the Influenza Vaccine Availability Tracking System (IVATS), a product of the National Influenza Vaccine Summit.

Interested in Learning More About Influenza Vaccine Production?
Read a report from the Health Industry Distributors Association, a non-profit trade association of medical products distributors who service healthcare providers, that explains the process that determines when and how vaccine reaches doctors, hospitals, nursing homes, and others.

Understanding the Dynamics of Influenza Vaccine Supply and Demand -- Five Issue Briefs. This series of briefs were prepared for the Assistant Secretary for Planning and Evaluation of the Department of Health and Human Services in October 2005.

Overview -- Summary and Assessment: roles and responsibilities of the influenza vaccine stakeholders.
 
Vaccine Economics: characteristics of the influenza vaccine market, industry regulatory requirements for vaccine productions, and factors affecting the profitability of vaccine production.


Who Buys It and Who Sells It: the vaccine supply chain and potential means for facilitating vaccine purchase and distribution.


Vaccine Manufacturing: the unique characteristics of the influenza vaccine, the structure of the industry, decisions about the amount of vaccine produced each year, investments in new technologies, and other factors.

The Chicken and the Egg: factors that impact the demand for vaccine and how they can affect supply.
 
Immunization Action Coalition  |  Litjen (L.J) Tan lj.tan@immunize.org  |   1573 Selby Ave - Suite 204  |  St. Paul MN 55104
Site managed by the Immunization Action Coalition  |  Laurel Wood, MPA, editor  |  Mitch Rothholtz, RPh, MBA, contributing editor